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Abstract
The precise role of CD4 T cell turnover in maintaining HIV persistence during antiretroviral
therapy (ART) has not yet been well characterized. In resting CD4 T cell subpopulations
from 24 HIV-infected ART-suppressed and 6 HIV-uninfected individuals, we directly mea-
sured cellular turnover by heavy water labeling, HIV reservoir size by integrated HIV-DNA
(intDNA) and cell-associated HIV-RNA (caRNA), and HIV reservoir clonality by proviral inte-
gration site sequencing. Compared to HIV-negatives, ART-suppressed individuals had simi-
lar fractional replacement rates in all subpopulations, but lower absolute proliferation rates
of all subpopulations other than effector memory (TEM) cells, and lower plasma IL-7 levels
(p = 0.0004). Median CD4 T cell half-lives decreased with cell differentiation from naïve to
Summary
HIV persistence is maintained by slow turnover of immature CD4 T cells and clonal
expansion of more differentiated cells
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TEM cells (3 years to 3 months, p<0.001). TEM had the fastest replacement rates, were
most highly enriched for intDNA and caRNA, and contained the most clonal proviral expan-
sion. Clonal proviruses detected in less mature subpopulations were more expanded in
TEM, suggesting that they were maintained through cell differentiation. Earlier ART initiation
was associated with lower levels of intDNA, caRNA and fractional replacement rates. In con-
clusion, circulating integrated HIV proviruses appear to be maintained both by slow turnover
of immature CD4 subpopulations, and by clonal expansion as well as cell differentiation into
effector cells with faster replacement rates.
Author summary
HIV infection is a life-long disease for which we do not currently have a cure. One reason
for this is that the virus goes into a dormant state and hides in CD4 T cell lymphocytes.
Many of the less mature infected cells slowly self-renew (i.e., replace themselves) over
time, whereas other types of infected cells rapidly proliferate and expand, and are replaced
more rapidly. In our study, we directly measured how rapidly different types of CD4 T
cells divide in treated people with HIV. In addition to confirming that less mature CD4 T
cell populations self-renew at a very slow rate, and that more mature cells proliferate and
expand at a more rapid rate, we also found that cell types that divide more rapidly are
more likely to contain HIV. By carefully defining how rapidly these different cell popula-
tions are replaced, we help inform studies of HIV cure interventions that specifically target
these discrete populations of HIV-infected cells.
Introduction
The major obstacle to an HIV cure is the stable persistence of integrated proviruses within
CD4 T cells during antiretroviral therapy (ART) [1–3]. While ART prevents active viral repli-
cation, reservoirs of replication-competent virus persist in latently-infected cells and viral
rebound occurs when ART is discontinued [4].
The cellular composition of the HIV reservoir is thought to be influenced by homeostatic
mechanisms governing the maintenance of a diverse CD4 T cell repertoire [5,6]. The size and
distribution of the CD4 T cell population is dependent on the production of new progenitor
cells, cell maturation, trafficking, and homeostatic as well as antigen-driven proliferation [5–
7]. Naïve and stem-cell memory CD4 T cells, while less commonly infected than more mature
subpopulations, may promote long-term viral persistence due to their renewal properties and
longer survival [8–13]. More mature memory populations are enriched for HIV proviruses
through undefined mechanisms [11,14]. Homeostatic cytokines (i.e., interleukin-7 or IL-7)
promote thymopoiesis and the survival of progenitor cells (e.g., naïve and central memory
cells) [15], while antigenic stimulation and other cytokines (e.g., IL-15) induce the expansion
of more differentiated cells.
Given the central role of memory cell homeostasis in maintaining the reservoir, studies of T
cell proliferation, differentiation, and death in treated HIV disease are needed. To date, most
studies have focused on the turnover of bulk CD8 and CD4 T cell populations as measured by
radioisotope labeling. Untreated chronic HIV infection has been associated with shorter half-
lives amongst subpopulations of the bulk CD4 T cell population as well as lower production
rates, which largely normalize after the initiation of ART [16,17]. Two distinct patterns of
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cellular accrual have been observed, with a biphasic pattern found in the memory/effector cell
population, representing shorter-lived and longer-lived subpopulations, and a low-level prolif-
eration rate in the longer-lived subpopulation, attributed to naïve CD4 T cells. The validation
of new phenotypic markers that define various maturational stages of CD4 T cell subpopula-
tions [18,19] now provides an opportunity to define the turnover of discrete subpopulations
and to examine the relationship of such turnover to HIV persistence during ART.
Since HIV proviruses integrate into multiple unique positions in the cellular genome, inte-
gration site analysis can be used to identify cells that have clonally expanded from a single
infected progenitor cell sharing the same integration site. Long-term ART-mediated viral sup-
pression seems to select for genetically-identical HIV variants in vivo [20,21], and specific HIV
integration sites (often in genes involved in cell proliferation and survival) have been associ-
ated with clonal expansion and persistence of infected cells in the periphery during effective
ART, with up to 40% of distinct integrants being clonally-expanded and persisting longitudi-
nally [22–24].
In this study, we used in vivo deuterium labelling via heavy water intake to define the turn-
over of resting CD4 T cell subpopulations in treated HIV infection. We also assessed how
these parameters may affect HIV persistence as well as how they might be altered by the timing
of initiation and the duration of ART.
Results
Participant characteristics
24 ART-suppressed HIV-infected individuals and 6 HIV-uninfected controls were recruited
into this study. As we were not able to enroll enough female participants who initiated ART
during very early infection, we restricted enrollment to men to avoid confounding by biologi-
cal sex. While not significantly different, median age was slightly older in HIV-uninfected than
in ART-suppressed participants (60 vs. 51 years, Table 1). As expected, HIV-infected partici-
pants had a lower median CD4 T cell count (573 vs. 647 cells/mm3 blood) and CD4/CD8 ratio
(1.14 vs. 2.1) than uninfected individuals (p<0.034). Reflecting our sampling strategy, the
ART-suppressed participants had a broad range of time to ART initiation (0.7 to 222 months
from estimated date of infection) and duration of suppressive ART (1.2 to 18.8 years after initi-
ation). HIV-infected participants had a median CD4 T cell count nadir of 335 cells/mm3 (2 to
664) and a median integrated HIV DNA level of 152 copies per million peripheral blood
mononuclear cells (4 to 1,887).
CD4 homeostatic proliferation is reduced in suppressed HIV infection
The proliferative capacity of resting CD4 T cell subpopulations was first assessed by comparing
blood samples from 24 ART-suppressed HIV-infected (HIV+) to 6 HIV-uninfected (HIV-)
participants. Enrichment of deuterium in saliva and plasma was measured repeatedly during
the first month of the 45-day heavy water labeling period [25]. The fractional replacement rate
of cells (fraction replaced per day) was estimated from in vivo deuterium enrichment in geno-
mic DNA, corrected for time-averaged deuterium exposure in body water, from the following
sorted resting (HLA-DR-) CD4 subpopulations: naïve (TN), stem-cell memory (TSCM), cen-
tral memory (TCM), transitional memory (TTM), and effector memory (TEM) cells (see gat-
ing strategy in S1 Fig). Because CD4 T cell counts as well as CD4 T cell subpopulations
proportions remained stable in periphery throughout the labeling period (S2A Fig), we can
assume that the fraction of proliferating/dividing cells incorporating deuterium and entering
the sampled pool is equivalently balanced by the fraction of cells leaving the pool. Label incor-
poration under steady-state conditions thereby allows calculation of cellular replacement rate
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and half-life within the sampled compartments (where half-life in the circulation is determined
by any route for leaving the sampled pool, including cell death, differentiation into other phe-
notypes, or migration to different anatomical compartments).
We focused our study on resting (HLA-DR-) CD4 T cell subpopulations since 100% of the
HLA-DR+ CD4 T cell population turns over within 14 days (S2B Fig). Based on overall frac-
tional synthesis (S2C Fig), the fractional replacement rates did not differ significantly between
HIV- and ART-suppressed HIV+ participants for any resting CD4 T cell subpopulation





























3693 Male 46 Positive 0.9 1.2 841 468 0.94 < 40 4
2641 Male 60 Positive 4.2 2.8 341 252 0.74 < 40 53
2609 Male 33 Positive 1.7 1.5 899 518 1.51 < 40 129
2647 Male 33 Positive 4.5 3.4 532 486 1.34 < 40 294
2531 Male 51 Positive 1.9 3.4 1163 618 1.9 < 40 48
2664 Male 46 Positive 4.1 2.7 637 509 0.96 < 40 <63
2606 Male 29 Positive 1.7 3.5 787 341 1.68 < 40 563
2454 Male 35 Positive 0.7 7.1 513 352 1.31 < 40 25
2661 Male 54 Positive 3.4 12.9 739 442 1.02 < 40 463
2522 Male 42 Positive 4.4 6.4 341 203 0.81 < 40 485
1473 Male 55 Positive 34.9 4.5 573 311 1.32 < 40 1144
1408 Male 31 Positive 45.5 3.1 637 357 1.14 < 40 292
1602 Male 38 Positive 24.4 3.5 626 480 2.3 < 40 14
3632 Male 31 Positive 20.8 1.8 902 664 1.74 < 40 100
1756 Male 29 Positive 6.8 4.1 582 229 0.97 < 40 <76
1597 Male 56 Positive 187.7 2.6 432 335 0.6 < 40 247
2610 Male 53 Positive 34.8 2.6 468 393 1.07 < 40 1887
2026 Male 61 Positive 85.5 16.7 383 132 0.67 < 40 28
2168 Male 55 Positive 222 13.4 377 300 0.35 < 40 151
2013 Male 67 Positive 122.5 18.8 687 13 1.35 < 40 121
2185 Male 59 Positive 39.1 11.5 523 2 1.37 < 40 69
2046 Male 51 Positive 69.4 17 747 10 0.76 < 40 258
2274 Male 54 Positive 13.1 11.8 486 280 1.23 < 40 152
2208 Male 64 Positive 114.5 7.1 437 54 0.98 < 40 374
Median - 51 - 20.8 4.1 573 335 1.14 < 40 140
[IQR] [33-56] [4.1-69.4] [2.8-11.8] [437-739] [203-480] [0.81-
1.37]
[56-354]
1806 Male 58 Negative NA NA 736 NA 3.05 NA NA
1852 Male 39 Negative NA NA 1570 NA 1.65 NA NA
1867 Male 63 Negative NA NA 584 NA 1.42 NA NA
1943 Male 61 Negative NA NA 1677 NA 2.28 NA NA
6532 Male 62 Negative NA NA 957 NA 2.29 NA NA
6561 Male 53 Negative NA NA 573 NA 1.99 NA NA
Median - 59.5 - - - 847 - 2.1 - -
[IQR] [50-62] [581-1597] [1.6-2.5]
Abbreviations: ART, antiretroviral therapy; CD4, CD4+ T cell; CD8, CD8+ T cell; DNA, deoxyribonucleic acid; HIV, human immunodeficiency virus; IQR, 25–75%
interquartile range; PBMC, peripheral blood mononuclear cells; RNA, ribonucleic acid.
https://doi.org/10.1371/journal.ppat.1009214.t001
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(Fig 1A). The absolute cell counts were lower for all CD4 subpopulations in suppressed HIV
+ compared to HIV- participants after controlling for age (p<0.0001, Fig 1B). There were no
obvious differences in CD4 subpopulation frequencies in blood by HIV serostatus (S3A Fig).
We then used the absolute cell counts, also known as pool sizes (cells per mm3 blood), and
fractional cell replacement rates (fraction of new cells produced by cell division per day) to cal-
culate the absolute proliferation rate of subpopulations (newly-divided cells per mm3 blood
per day). Treated HIV+ were found to have a mean 45% lower absolute CD4 T cell prolifera-
tion rate across TN, TSCM, TCM, and TTM subpopulations compared to HIV- participants
(p<0.016 from a linear mixed model assuming equivalent differences across subpopulations
after adjustment for age as a continuous variable, Fig 1C), though rates appeared similar in the
TEM population. Of note, absolute proliferation rates differed by CD4 T cell subpopulation
among HIV-infected individuals.
Homeostatic cytokine levels and thymic function
Since the impact of HIV infection on lowering the absolute proliferation rates was primarily
observed within less mature CD4 T cell subpopulations that are maintained by IL-7 [26], we
compared plasma IL-7 levels between groups. Compared to HIV- participants, ART-sup-
pressed participants had significantly lower plasma IL-7 concentrations (6.8 vs. 12.1 pg/ml,
Fig 1. Absolute CD4 T cell proliferation and plasma IL-7 levels are decreased in treated HIV infection. Fractional
cell replacement rates (fraction of new cells per day) and absolute proliferation rates (newly-divided cells per mm3 per
day) were assessed in resting CD4 T cell subpopulations and compared between 24 HIV-infected (HIV+) and 6
uninfected (HIV-) participants in: naïve (TN), stem-cell memory (TSCM), central memory (TCM), transitional
memory (TTM) and effector memory (TEM) cells. Medians and interquartile ranges are represented, and only
significant p values are shown. A. The fractional replacement rate was inferred from the rate of incorporation of
deuterium into the genome and is expressed as the fraction of the cells replaced per day (also called k, a constant rate
with units day-1), and compared between HIV+ and HIV- participants across all subpopulations. B. The pool size was
derived from measured CD4 T cell count and frequency in peripheral blood. The p value reflects the difference in pool
size between HIV+ and HIV- across all subpopulations in a linear mixed model, which accounts for clustering between
subpopulations within individuals. C. The absolute proliferation rate was calculated from the fractional replacement
rate and pool size, as the number of cells produced per day per mm3 of blood. The p value assesses the difference
between HIV+ and HIV- across TN, TSCM, TCM, and TTM subpopulations in a linear mixed model. D. Plasma levels
of interleukin-7 (IL-7) (pg/ml) were compared between HIV+ and HIV- participants.
https://doi.org/10.1371/journal.ppat.1009214.g001
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p = 0.0004, Fig 1D). Nevertheless, there was no evidence for a correlation between plasma IL-7
levels and absolute proliferation rates or fractional replacement rates within any subpopulation
among HIV+ participants.
As IL-7 may promote thymopoiesis as well as homeostatic proliferation in the periphery,
we also assessed differences in thymic output between groups by measuring the levels of signal
joint T-cell Receptor Excision Circles (sjTREC) in cell subpopulations. There was also no evi-
dence of a difference in thymic output as reflected by relative or absolute sjTREC content in
peripheral resting CD4 T cells between HIV+ and HIV- participants, even after adjustment for
age (S3B Fig). Lastly, just as there were no differences in TEM absolute proliferation rates
between HIV+ and HIV- participants, there were also no differences in plasma IL-15 levels, a
cytokine that promotes effector cell proliferation and differentiation (S3C Fig).
HIV is enriched in resting effector memory CD4 T cells with relatively
short half-lives
From the measured fractional replacement rates, we calculated the cellular half-lives for each
of the CD4 T cell subpopulations during ART-suppressed HIV infection as t1/2 = ln(2)/k,
where k is the fractional replacement rate in day-1. In general, we found shorter half-lives with
increasing cell differentiation (Fig 2A, p for trend<0.001). For instance, TN had the longest
median half-life (2.9 years) while TEM had the shortest (3.1 months).
Fig 2. HIV is preferentially harbored in CD4 T cell subpopulations with relatively short half-lives. HIV genome
levels and cellular half-lives were measured in 24 HIV-infected participants within the following resting CD4 T cell
subpopulations: naïve (TN, yellow circle), stem-cell memory (TSCM, purple square), central memory (TCM, pink
upward triangle), transitional memory (TTM, blue downward triangle) and effector memory (TEM, green diamond)
cells. Medians and interquartile ranges are represented, and only significant p values are shown. Undetectable values
were assigned a value equal to the threshold of detection based on the number of cells analyzed. A. The cellular half-life
for each sorted cell subpopulation is shown in days. A p value for trend was statistically assessed across all five
subpopulations. B. Levels of integrated HIV DNA and cell-associated HIV RNA were measured and are presented on a
log10 axis as copy number per million cells. Medians are represented and each symbol represents a single participant
sample. Values under the level of detection of the assay are represented in a black circle. A p value for trend was
statistically assessed across all five subpopulations. C. The relationship between HIV genomes and cellular half-lives is
shown for all cells. Integrated HIV DNA and cell-associated HIV RNA were measured and presented as copy number
per million CD4 T cells. Cellular half-lives are expressed in days. D. Hierarchical clustering based on Spearman
correlations among integrated HIV DNA frequency in each cell subpopulation.
https://doi.org/10.1371/journal.ppat.1009214.g002
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We next assessed the distribution of HIV DNA and RNA within cell subpopulations with
defined half-lives. Integrated HIV DNA (intDNA) and total cell-associated HIV RNA (caRNA,
using LTR primers) levels were measured within the same resting cell subpopulations (Fig 2B).
Of all subpopulations, TEM were most highly enriched for both HIV intDNA (p<0.02) and
caRNA (p<0.009) and, overall, infection frequencies increased with cellular differentiation (p
for trend<0.001). Despite the greater abundance of naïve CD4 T cells in peripheral blood than
other subpopulations, cells that were more differentiated also contributed a greater proportion
to the total circulating intDNA (p<0.014) and caRNA levels (p<0.0003, S4A Fig) than those
that were less differentiated. Across all subpopulations, shorter cellular half-lives were associated
with higher total intDNA (r = -0.55 and p<0.0001) and caRNA levels (r = -0.56 and p<0.0001,
Fig 2C), though this relationship was only significant within the TSCM subpopulation (S4B
Fig). Interestingly, intDNA levels within CD4 T cell subpopulations tended to correlate with
each other in a pattern consistent with linear T cell differentiation (Fig 2D). In an unbiased clus-
tering analysis, intDNA levels within TN tended to correlate more strongly with those in TSCM
than those in the more differentiated memory populations. Similarly, TCM, TTM and TEM
intDNA levels tended to correlate more strongly with each other than with those in TN.
We also assessed the patterns of HIV transcriptional activity within each resting CD4 sub-
population using methods published previously [27], and assessed the following transcripts:
U3-U5 “read-through” (suggesting transcriptional interference), TAR loop (transcription ini-
tiation), R-U5-tRNA-binding (“long”, 5’ elongation), U3-PolyA tail (“PolyA”, transcription
completion), and multiply-spliced Tat-Rev (“Tat-Rev”, multiple splicing) (S5 Fig). While the
pattern of transcriptional blocks was similar in the different cell subpopulations assessed, TN
had lower levels of initiated (TAR) and 5’ elongated (long) HIV transcripts per provirus than
each of the more differentiated TCM, TTM and TEM subpopulations (p<0.031). The levels of
polyadenylated (PolyA) or multiply-spliced (Tat-Rev) HIV transcripts per provirus were simi-
larly low in all CD4 subsets.
Clonal expansion of HIV proviruses is associated with cellular differentiation
To investigate the cellular mechanisms that contribute to the maintenance of HIV over time,
we measured the clonality of HIV proviruses in each CD4 subpopulation. Integration sites
were characterized in 12 of the 24 participants, and the total number of HIV integrants as well
as the maximum clone size are presented in Table 2. In these events, cells deriving from clonal
expansion were defined by a difference in amplicon length and at least three amplicons pres-
ent. The HIV clonality index increased with cellular differentiation, from a median 0 in TN to
0.07 in TEM (p for trend<0.025, Fig 3A). We also calculated the Gini index, a test of statistical
dispersion representing the degree to which clones are expanded in high numbers within each
cell population. The Gini index tended to increase with greater cellular differentiation (p for
trend<0.003, Fig 3B). Identical clones were sometimes observed in more than one CD4 sub-
population, often with greater degree of expansion in the more differentiated TEM subpopula-
tion (S4C Fig). We also explored the types of genes, grouped by their known biological
functions, in which unique HIV integration sites were detected. The biological function of the
genes harboring HIV integrants were similar in multiple cell subpopulations, and were often
related to cell biology, including immune processes and signal transduction (Fig 3C).
Early ART decreases cell fractional replacement rates and HIV reservoir
size in resting CD4 T cells
We also assessed the impact of the timing of ART initiation on fractional replacement rates
(inversely correlated to cellular half-lives) and HIV reservoir measures. Earlier ART initiation
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was associated with both lower fractional replacement rates (Fig 4A) and higher CD4 counts
(Fig 4B), associations that remained significant after adjustment for age and ART duration. In
cells that harbor the majority of proviruses (i.e. TCM, TTM, and TEM), later ART initiation
Table 2. Total number of HIV integrants and maximum clone size.
Participant
ID























1408 9 0 24 3 7 2 40
1473 8 0 4 0 25 0 43 5 80
1597 3 0 28 0 18 0 5 2 54
2046 14 3 28 0 2 0 44
2208 30 0 5 0 13 0 15 2 12 0 75
2454 3 2 253 3 256
2522 2 0 3 0 7 0 12
2531 2 0 3 2 11 3 16
2606 14 4 14
2610 53 0 6 0 57 3 86 2 47 3 249
2661 3 0 51 0 54
3632 152 3 140 6 8 0 300
Total 96 14 286 345 453 1194
https://doi.org/10.1371/journal.ppat.1009214.t002
Fig 3. Cellular differentiation is associated with clonal expansion of HIV proviruses. HIV integration site analysis
was performed on the following resting CD4 T cell subpopulations: naïve (TN), stem-cell memory (TSCM), central
memory (TCM), transitional memory (TTM) and effector memory (TEM) cells. Medians and interquartile ranges are
presented and only significant p values are shown. A. The HIV clonality index is calculated as the proportion of
integration sites that are clonally expanded over the total number of integration sites detected. B. The Gini index is a
measure of statistical dispersion intended to represent the integrated events distribution of an integration position,
with values ranging from 0–1 from perfectly even (uniform clones) to highly skewed and uneven (many small clones
and a few vastly expanded clones). C. Proportion of total unique HIV integration sites detected across all CD4 T cell
subpopulations that fall within a given reactome (a set of linked genes, defined by an open source database of biologic
pathways) and CD4 subpopulation. Specifically, the numbers reflect the total number of unique integration sites within
a given reactome and CD4 subpopulation divided by the total number of integration sites detected across all CD4
subpopulations, multiplied by 100. Low frequencies are depicted in red while high frequencies are in purple.
https://doi.org/10.1371/journal.ppat.1009214.g003
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was associated with higher levels of both integrated HIV DNA and cell-associated HIV RNA
(Fig 4C), but not with IL-7 levels. Finally, we assessed the impact of the duration of ART on
our outcomes, and found no evidence for a correlation between duration of ART and cellular
fractional replacement rates (S6A Fig), HIV DNA, nor cell-associated HIV RNA (S6B Fig).
Discussion
The persistence of HIV in resting CD4 T cells is the primary barrier to an HIV cure. While
examples of clonal proliferation of HIV-infected CD4 T cells have been described [22,28–32],
our study is the first to characterize the extent to which the proliferation and differentiation of
resting CD4 T cell subpopulations contribute to HIV persistence. We made several important
observations. First, the fractional replacement rates increased (while half-lives decreased) as
cells matured from naïve to the effector memory phenotype, with rates similar between those
with treated HIV disease and those who were uninfected. Second, ART-suppressed partici-
pants had lower absolute proliferation rates of less mature CD4 T cell subpopulations and
lower IL-7 levels than HIV-negative individuals. Third, while naïve CD4 cells harbor less inte-
grated HIV DNA than more mature subpopulations [12], they have extremely long half-lives
Fig 4. Early ART is associated with lower fractional replacement rate and HIV burden in resting CD4 T cell
subpopulations. Measurements of the fractional cell replacement rate and HIV genome levels were performed in
resting CD4 T cell subpopulations: naïve (TN), stem-cell memory (TSCM), central memory (TCM), transitional
memory (TTM) and effector memory (TEM) cells. Each symbol represents a participant’s sample and the data are
plotted on a log10-scale axis. Antiretroviral therapy (ART) initiation time is expressed in months. Spearman
correlation coefficients (ρ) and associated p-values are reported in each subplot. A. The relationship between the
fractional replacement rate and the initiation time of ART was assessed. The fractional replacement rate (k) is
estimated as cells produced per day. B. The relationship between peripheral CD4 T cell count and the initiation time of
ART was assessed. CD4 T cell count is estimated as cells per mm3 of blood. C. The associations between HIV nucleic
acid levels and ART initiation time are shown for all participants. Integrated HIV DNA and cell-associated HIV RNA
are measured and presented as copy number per million cells. Cell subpopulations that contribute most of the HIV
reservoir are shown here, i.e., TCM, TTM and TEM. Undetectable values were assigned a value equal to the threshold
of detection based on the number of cells analyzed.
https://doi.org/10.1371/journal.ppat.1009214.g004
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and seem to be maintained by slow homeostatic proliferation in contrary to memory cells that
have higher turnover. Fourth, we observed enrichment for clonal proviruses in more mature
memory cells, suggesting that T cell differentiation and clonal expansion contribute meaning-
fully to the steady-state level of circulating HIV proviruses. Indeed, provirus levels were most
strongly enriched in cells with the highest turnover rates. Lastly, earlier ART initiation was
associated with lower fractional replacement rates of most CD4 T cell subpopulations, suggest-
ing that the contribution of proliferation to HIV persistence is likely to be greatest in those
who initiated ART at later disease stages.
Our finding that the fractional replacement rate of resting CD4 subpopulations is compara-
ble in ART-suppressed HIV-infected and uninfected individuals mirrors findings in an earlier
study [16]. By 12–36 months of ART, the fractional replacement rates of total CD4 and CD8 T
cells tended to normalize, with greater production of cells rather than longer half-lives of circu-
lating cells. In HIV-negative participants, in vivo labeling with deuterated glucose revealed that
effector memory cells have higher turnover than central memory cells [33]. These results are
consistent with ours using a deuterium labeling method that provides a much more reliable
assessment of turnover in cellular populations like TN and TCM that turnover more slowly.
Our observation of a substantially longer half-life in naïve cells than all other memory cells is
in accordance with previously-reported data describing a biphasic accrual and decay kinetics
in memory/effector but not in naïve cells [17]. Our study also provides novel data on the turn-
over of TSCM in the context of HIV infection. It was initially suggested, for instance, that
stem-cell memory T cells were maintained through an enhanced capacity for self-renewal [34].
Stable isotope labeling in HIV-negative individuals demonstrated instead that they are main-
tained by ongoing proliferation, in accordance with our findings of a relatively shorter half-life
close to that of memory cells [35]. Our study extends these observations to ART-suppressed
HIV-infected participants.
Despite comparable fractional CD4 replacement rates, we found that ART-suppressed par-
ticipants had lower absolute proliferation rates than HIV-negative participants in all CD4 T
cell subpopulations except TEM, and also had lower plasma IL-7 concentrations. The earlier
study discussed above also found lower absolute proliferation rates of CD4 T cells in treated
HIV infection [16]. While untreated HIV infection has been associated with higher plasma IL-
7 levels, in part due to increased production and decreased clearance in the setting of lympho-
penia [36,37], the ART-suppressed participants with reconstituted CD4 compartments
reported here had lower IL-7 concentrations than uninfected individuals. This could be due to
a decreased production of IL-7 from lymphatic endothelial cells in secondary lymphoid tissues,
presumably as a consequence of lymphoid fibrosis and collagen deposition following HIV
infection [38,39]. Although a previous study showed that serum IL-7 levels normalized one
year after the initiation of ART [40], we found lower levels in HIV+ participants here. While
this difference could be due to the small sample size of the HIV-negative control group, it is
worth noting that the cohort of participants recruited in this other study had low CD4 T cell
counts while all of our participants had normalized CD4 T cell counts. It has been demon-
strated that CD4 T cell lymphopenia and/or decreased CD127 (IL-7R alpha) availability drives
IL-7 levels up as a consequence of increased production [41], decreased use, or CD127-me-
diated clearance [36].
Interestingly, the decreased absolute cell proliferation rates that we observed in treated HIV
infection appeared to be limited to less mature CD4 subpopulations that generally express the
IL-7 receptor specific alpha-chain, CD127, possibly suggesting a specific defect in homeostatic
IL-7-driven proliferation despite preserved IL-15- and antigen-driven proliferation with differ-
entiation. Additionally, those with earlier ART initiation had slower fractional replacement
rates for most subpopulations than those initiating ART later, perhaps as a consequence of
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higher CD4 T cell counts, lower chronic immune inflammation and thus a reduced depen-
dency on cell proliferation (whether homeostatic or antigen-driven). A practical inference is
that the contribution of cell proliferation to HIV persistence seems to be greater among indi-
viduals who start ART at later disease stages.
Our assessment of HIV burden within naïve CD4 T cells is also consistent with findings of
other reports confirming the persistent infection of naïve CD4 T cells, and in some studies,
naïve T cell progenitors [11–13, 42–44]. Although harboring lower levels of total HIV DNA
overall, naïve cells showed greater contribution of intact proviruses than central memory cells
in chronically-infected participants [42]. While others did not find a consistent enrichment in
CD4 T cells subpopulations [45], our observation of relatively long half-lives in naïve cells
could be one important mechanism underlying the long term persistence of proviruses, as well
as their potential to differentiate into other maturation stages upon stimulation. An earlier
study demonstrated the production of as much virus from naïve cells as from central memory
cells following in vitro stimulation with latency-reversing agents, further emphasizing the
underestimated role of naïve CD4 T cells in HIV persistence [46].
Nevertheless, our integration site analysis only found expanded identical clonal integration
sites in central, transitional and effector memory cell populations, suggesting that clonal prolif-
eration and differentiation are more important mechanisms for viral persistence in memory
than in naïve CD4 T cells. Consistent with different mechanisms of persistence in naïve and
memory CD4 cell populations, we found much stronger correlations between memory CD4 T
cell subsets in integrated HIV DNA and cell-associated HIV RNA levels than between memory
and naïve CD4 cells. Collectively, these observations are consistent with a model whereby
long-lived naïve cells are maintained by slow homeostatic proliferation resulting in a low HIV
clonality index [47], while memory cells are supported by clonal expansion and antigenic pro-
liferation resulting in larger clonally expanded HIV populations [48]. We recognize that other
biological mechanisms might play a role including shared clearance mechanisms or cell differ-
entiation. In previous studies, cellular proliferation has been implicated as a direct contributor
to the clonal expansion of HIV proviruses in memory T cells, based on the expansion of identi-
cal HIV sequences and/or integration sites, largely in effector cell populations [22,29,49–57].
While infected naïve CD4 T cells are less likely than memory cells to undergo antigen-
induced clonal proliferation, it is still plausible that at some point, they could also give rise to
expanded memory cell progeny and contribute to the persistence of HIV genomes through
both homeostatic proliferation and differentiation, even though we have not observed it here
given our limited sampling. We also observed that resting HIV-infected naïve CD4 T cells
were less likely to initiate HIV transcription than memory cells. Presumably, lower transcrip-
tional activity might render infected naïve cells less susceptible to immune-mediated clearance
and less responsive to latency reversal interventions [58].
We also observed an enrichment of HIV in more differentiated CD4 T cell subpopulations
that have more rapid fractional replacement rates. HIV genomes were more likely to be clon-
ally expanded in these cells as compared to their putative progenitor cells, as found by others
[59–61]. Namely, effector memory cells showed the highest turnover rate and infection fre-
quency, and were previously shown to play a major role in the waxing and waning of the HIV
reservoir over time [48,62,63]. Consistent with other recent reports [45,54], we also observed
identical HIV integration sites across memory subsets, further reinforcing the concept that
HIV-infected cells are maintained by both clonal expansion and cell differentiation. Impor-
tantly, cell differentiation into effector memory phenotype was shown to help facilitate HIV
latency reversal [64]. The idea that cell differentiation participates in maintaining HIV provi-
ruses has been demonstrated elsewhere [9,65], and although we did not find identical
sequences between naïve, stem-cell memory and other memory phenotypes because of
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sampling issues, we did find common integration sites and very strong HIV reservoir correla-
tions in central, transitional and effector memory cells. While this may be due to HIV integra-
tion into oncogenes [22,66], only 1.3% of all integration sites in these individuals were found
directly within or <10,000 base pairs distant to oncogenes.
We also found that the contribution of cellular proliferation to HIV persistence in periph-
eral blood is greatest among those who initiated ART later in the disease course. Those initiat-
ing ART in the first several months of infection tended to have lower fractional replacement
rates of most CD4 subpopulations, which may reflect greater CD4 recovery during ART (and
less of a need for homeostatic proliferation) [67]. It also may reflect less effector T cell prolifer-
ation as a consequence of decreased exposure to or better control over prevalent antigens, thus
decreasing levels of bystander immune activation and inflammation [68]. Whatever the mech-
anistic explanation, it suggests that anti-proliferative approaches to reducing HIV reservoirs
may be more effective in individuals who initiated ART late rather than early after infection.
There are several limitations of our study that deserve comment. Since all of our analyses
related to HLA-DR- CD4 subpopulations, events that occur during transient activation of cells
in vivo (such as enhanced HIV transcription) were not recorded [69,70]. All of our observa-
tions were also restricted to circulating cells. Tissue-based T cells may shed additional mecha-
nistic light on reservoir persistence and deserve future analogous analysis. Our turnover rate
estimates include both infected and uninfected cells. Thus, our implicit assumption is that
HIV-infected cells have similar proliferation and fractional replacement rate characteristics as
uninfected cells of the same maturational phenotype, which might not be true. Current experi-
mental limitations preclude sorting and turnover measurements of the same exact cells, which
would be necessary to interrogate this assumption. We acknowledge the fact that we have not
measured intact HIV proviruses in this study as only evaluating integrated HIV DNA does not
inform the replication-competency of the reservoir. One last limitation of our analysis is the
lack of inclusion of female participants in our study. Since biologic sex plays an important role
in modulating T cell biology [71,72], future studies focused on the impact of sex differences on
HIV reservoirs and cellular turnover are warranted.
In summary, circulating HIV proviruses appear to be maintained by 3 main processes: 1) slow
turnover of immature CD4 subpopulations with less HIV transcriptional activity, 2) cell differen-
tiation from immature to mature cell types, and 3) clonal expansion of effector cells with fast
replacement rates. Our study enhances the mechanistic understanding of these dynamics and
highlights the challenges and opportunities for curative therapies attempting to modulate
Human immunology such as shock-and-kill, block-and-lock or anti-proliferative therapies.
Materials and methods
Participant characteristics
Under the auspices of a study approved by the University of California San Francisco Commit-
tee on Human Research, twenty-four HIV-infected and six HIV-uninfected participants were
recruited between 2015 and 2017 from the clinic-based SCOPE and OPTIONS cohorts at
Zuckerberg San Francisco General Hospital. All participants were over 18 years old and pro-
vided written informed consent. The SCOPE cohort enrolls chronically HIV-infected individ-
uals while the OPTIONS cohort enrolls individuals <12 months (before 2003) and <6 months
(after 2003) after HIV antibody seroconversion. The estimated dates of infection were calcu-
lated from the first positive HIV RNA assay or antibody seroconversion tests, as previously
described [73]. HIV-infected participants were required to be virally suppressed on ART upon
study entry. Duration of viral suppression was estimated based on clinic records (typically
assessed every 3–6 months). We stratified sampling of participants across a range of time to
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ART initiation (0.7 to 222 months) and duration of ART suppression (1.2 to 18.8 years), ensur-
ing sufficient overlap in each of these parameters to allow for valid adjusted analysis of the
independent contributions of ART timing and duration to biological measurements. All but
one of the HIV-uninfected participants were chosen to be seropositive for CMV infection to
match the CMV status of our HIV-infected cohort.
Isolation of CD4 T cell subpopulations
All participants underwent large blood draws and leukaphereses performed as outpatients.
PBMC were isolated and viably cryopreserved. Frozen PBMC were thawed and CD4 T cells
enriched with the EasySep Human CD4+T Cell Negative Selection Enrichment Kit (Stemcell).
CD4 T cells were stained with Live/Dead Fixable Aqua (Life Technologies) and the following
monoclonal antibody cocktail: anti-CD3-FITC, anti-CD4-AlexaFluor700, anti-CCR7-PE-Cya-
nine7, anti-CD27-APC, anti-HLA-DR-APC H7, anti-CD57-Brilliant Violet 421, and anti-
CD95-PE (Becton Dickinson) as well as anti-CD45RA-ECD (Beckman Coulter). Cells were
sorted on a FACS ARIA II flow cytometer (BD Biosciences) to>97% purity, as follows: from
singlets PBMC, live (Aqua-) CD3+CD4+ lymphocytes were selected based on size and granu-
larity criteria. We then sorted either the activated (HLA-DR+) fraction, or the following sub-
populations within the resting (HLA-DR-) fraction according to their expression of
phenotypic markers: naïve (TN, CD45RA+CCR7+CD27+CD57-CD95-), stem-cell memory
(TSCM, CD45RA+CCR7+CD27+CD57-CD95+), central memory (TCM, CD45RA−CCR7
+CD27+), transitional memory (TTM, CD45RA−CCR7−CD27+), effector memory cells
(TEM, CD45RA−CCR7−CD27−) and terminally-differentiated (TTD, CD45RA+CCR7-).
Dry pellets of these sorted cell populations were snap-frozen at -80˚C. Flow cytometry data
were analyzed on FACSDiva v8.0.1 (BD Biosciences) and FlowJo v8.7 (Tree Star).
We initially included in our study resting terminally-differentiated CD4 T cells (TTD) but
given the fragility of CCR7 staining, we suspected that there may have been contamination of
TN into TTD. To investigate this possibility, we measured T cell Receptor Excision Circle
(TREC) content to find that TTD had an unexpectedly higher sjTREC level than TEM (see
S3B Fig). Assuming that the true sjTREC content of TTD is no higher than that of TEM, we
estimated a median of 20% contamination. As the sorted TTD population likely reflected a var-
iable mix of TN and TTD cells, we could not be confident in the interpretation of data in the
TTD population and have therefore excluded these data from this report.
In vivo labeling with deuterated (heavy) water
Participants were provided 70% deuterated water (Sigma-Aldrich), with an oral intake of 50
ml three times per day for the first 7 days and 50 ml twice per day for the remainder of the 45
day-long labeling period. Peripheral blood was collected at baseline and at days 15, 30, and 45.
Plasma was collected at all four time points and saliva samples were collected at days 7 and 21
during the first month to assess body water enrichment, which is used in the calculation of cel-
lular replacement rate described below [17,25].
Measurement of plasma deuterium oxide enrichment
Plasma deuterium oxide (2H2O) enrichment analysis was performed using a modified acetone
equilibration [74]. Briefly, water was distilled from 100μl aliquots of plasma or saliva in
inverted microvials placed in a 70˚C glass bead bath. The collected distillate was reacted with
5μl acetone and 1μl 10N NaOH, and left at room temperature for 18–24 hours. Acetone was
extracted from treated samples using 300ul hexane and, after drying hexane extracts with
Na2SO4 crystals, acetone was analyzed by gas chromatography/mass spectrometry (GC/MS).
PLOS PATHOGENS HIV persistence is maintained by cell proliferation & differentiation
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009214 January 19, 2021 13 / 24
A standard curve of percent enrichment was prepared gravimetrically from 100% enriched
2H2O. GC/MS analysis of acetone was performed by quadrupole gas chromatography/mass
spectrometry (Agilent 6890/5973) using electron impact ionization mode and SIM ions of m/z
58.2 and 58.3 for acetone M0 and M+1. The column used was a DB-17MS, 30M x 0.25mm I.
D., 0.25μm film thickness (J&W Scientific, Agilent).
Measurement of deuterium enrichment in cellular genomic DNA
The stable isotope/mass spectrometric method for measuring cell proliferation has been
described previously [25], and included additional precautions and controls required for work-
ing with low cell count samples. Isolated DNA (DNEasy extraction kit, Qiagen) was further
hydrolyzed and dephosphorylated, and deoxyribonucleosides were derivatized using penta-
fluorobenzyl hydroxylamine (PFBHA) solution in acetic acid (Sigma-Aldrich). GC/MS analysis
of the derivatized deoxyribose was performed as above using negative chemical ionization
mode (methane) and a DB-17MS column. The SIM ions for the PFBHA derivative of deoxyri-
bose were m/z 435, 436, and 437 respectively for M0, M1, and M2. The mole fraction of the M1
mass isotopomer was calculated as the ratio of peak areas: M1/(M0+M1+M2). Label incorpo-
ration in experimental samples was measured as the excess mole fraction of M1 (EM1) relative
to the M1 mole fraction of abundance-matched unlabeled standards: [M1/(M0+M1+M2)sam-
ple]–[M1/(M0+M1+M2)standard]. The value of f, the fraction of newly synthesized DNA
strands or, equivalently, the fraction of newly divided cells, was calculated as EM1/EM1�, where
EM1� represents the maximal or asymptotic EM1 enrichment possible in 100% newly-divided
cells under the measured mean 2H2O exposure in the participant [25]. EM1
� values were calcu-
lated using measured body water enrichment and the previously determined relationship
between body water enrichment and theoretical maximum possible EM1� for deoxyribose [25].
Fractional replacement rates, which can be expressed as a rate constant (k), were calculated
by assuming a model of exponential clearance of EM1. That is, the amount remaining after
time t can be expressed as EM1(t) = EM1(t = 0)exp (−kt). Fractional replacement rate is then
estimated by fitting this equation to experimental data (using least-squares comparison with
the 4 time points). From replacement rates, cellular half-lives are subsequently calculated from
the newly-divided fraction (f) of cells for each subpopulation as follows: f = 1-exp (−kt) and t1/2
= ln(2)/k. These half-lives can be interpreted as the time that elapses before half of the cells of a
certain subpopulation leave the pool via cell death, differentiation to other phenotypes or traf-
ficking to other anatomic compartments. Importantly, we verified that in all cases, absolute
subpopulation cell counts remained stable throughout the 45-day heavy water labeling period
(S2 Fig) [25]. This ensured label clearance was not due to cell population changes, but rather
turnover and dilution of deuterium labelled DNA.
Quantification of homeostatic cytokines IL-7 and IL-15
Plasma samples were collected and immediately stored at -80˚C. Thawed samples were assayed
in the Enzyme-Linked ImmunoSorbent Assay Quantikine assay (R&D Systems), per the man-
ufacturer’s recommendations. The standard curve of the IL-15 kit was further diluted to reach
a range 10-times lower than indicated. All samples were run in batch and in duplicate, and
read on a Molecular Devices SpectraMax M3. Reading was performed at 490nm and a 650nm
correction was applied to all samples.
Cell-associated HIV RNA quantification
Total RNA was extracted using the Allprep DNA/RNA/miRNA Universal Kit (Qiagen) with
on-column DNase treatment (Qiagen RNase-Free DNase Set). HIV RNA levels were
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quantified with a qPCR TaqMan assay using LTR-specific primers F522-43 (5’ GCC TCA
ATA AAG CTT GCC TTG A 3’; HXB2 522–543) and R626-43 (5’ GGG CGC CAC TGC TAG
AGA 3’; 626–643) coupled with a FAM-BQ probe (5’ CCA GAG TCA CAC AAC AGA CGG
GCA CA 3) on a StepOne Plus Real-time PCR System (Applied Biosystems, Inc.) [75]. Up to
500 ng of total RNA per sample were characterized in triplicate, and copy numbers were deter-
mined by extrapolation against a 7-point standard curve (1–10,000 copies). The input cell
number in each PCR well was estimated using independent qPCR measurement of the cellular
housekeeping human RPLP0 gene.
Integrated HIV DNA quantification
Total DNA was extracted using the Allprep DNA/RNA/miRNA Universal Kit (Qiagen). Inte-
grated HIV DNA copies were quantified using a two-step PCR reaction, as previously
described [76], with modifications where isolated genomic DNA was used for PCR amplifica-
tion instead of whole cell lysates. Integrated HIV DNA was pre-amplified with two Alu prim-
ers and a primer specific for the HIV LTR region, in addition to primers specific for the CD3
gene to determine cell counts. Nested qPCR was then used to amplify HIV and CD3 sequences
from the first round of amplification. Specimens were assayed with up to 500 ng cellular DNA
in triplicate and copy number was determined by extrapolation against a 5-point standard
curve (3–30,000 copies), using extracted DNA from ACH-2 cells.
Integration site analysis
HIV integration sites were assessed as previously described [77]. Genomic DNA (gDNA) was
isolated with the Blood & Cell Culture DNA Mini Kit (Qiagen). Random fragmentation was
achieved by treating 1.5 μg gDNA replicates for 20 minutes with NEBNext dsDNA fragmen-
tase (New England Biolabs) to obtain short 200–1200 bp fragments, purified at a 1:1 ratio with
AMPure XP (Agencourt Beckman Coulter). Products were end-repaired and A-tailed using
the end-repair ligation module (New England Biolabs), and 10 pmol of linker was ligated to
the products according to the manufacturer’s instructions. The internal HIV sequences were
digested by BglII (New England Biolabs). Amplification of purified products was performed
using a nested approach using described primers (Table 3), and subsequently quantitated
using Nanodrop (Thermo Fisher). Up to 12 samples were pooled in equimolar amounts per
library, and a sequence library was prepared using 500 ng of pooled product in the Kapa
Hyper Library prep kit (Kapabiosystems). The library was further quantified using qPCR and
sequenced by 300 bp paired-end sequencing on Illumina MiSeq.
To identify an HIV integration site, the Miseq reads were paired and each was associated
with a multiplex-identifier (MID) sequence on either end of the LTR and linker-based sequence
Table 3. Linker and primer sequences used for HIV integration sites analysis.
Name 5’ modification Sequence 3’ modification
Linker top - g�cagcgataacaatttcacggcgccactgcaggacgtac�t�g�t�t -
Liker bot Phosphorylated a�cagtacgtcctgcagtggcgcgccttgactgagcttta Dideoxycytosine
LTR 1st Biotinylated cttaagcctcaataaagcttgccttgag -
Linker 1st - gcagcggataacaatttcacg -
LTR 2nd MID tgactctggtaactagagatccctcag -
Linker 2nd MID tcactgcaggacgtactgtt -
Sequences used for primers and linkers to detect HIV integration sites. The star (�) indicates phosphorothiated nucleotide. MID stands for multiplex identifier sequence.
https://doi.org/10.1371/journal.ppat.1009214.t003
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products. Sample read pairs were subsequently checked for linker primer sequence, LTR primer
sequence, and the remaining LTR nucleotide sequence ending on the nucleotide sequence CA.
Matched read pairs after the LTR or linker primer sequence were trimmed to 50-base pairs and
grouped according to 100% sequence match. Grouped sequences with�3 reads were used for
chromosomal alignment using the Blat-UCSC Genome Browser (GRCH38/hg38). An HIV
integration site was determined to be “clonal” if the results had�2 reads, and the frequency was
determined by a length difference of>3 bases between the amplicons.
Integration site clonality was summarized using the Gini index (G): a measure of statistical
dispersion originally defined to quantify unevenness in distributions of income inequality and
applied to sequence clonality previously for HTLV-I virus [78]. Mathematically, it is the sum
of absolute differences among all pairs of clone sizes, normalized by the average clone size hci.




jjci   cjj where n is the number of clones found. Enrichment for integra-
tion of HIV in specific genes and pathways were assessed by pooling the integration sites per
subpopulation using the online tool Reactome [79] as follows: the proportion of total unique
HIV integration sites detected across all CD4 T cell subpopulations that fall within a given
reactome (a set of linked genes, defined by an open source database of biologic pathways) and
CD4 subpopulation. Specifically, the numbers in Fig 3C reflect the total number of unique
integration sites within a given reactome and CD4 subpopulation divided by the total number
of integration sites detected across all CD4 subpopulations, multiplied by 100.
Measurement of sjTRECs levels
DNA was extracted using QuickExtract (Lucigen) according to manufacturer’s instructions.
Briefly, cell pellets were resuspended at 10,000 cells/μL and heated at 65˚C for 20 minutes with
intermittent vortexing, followed by heating at 90˚C for 5 minutes. DNA was then isolated at a
2:1 bead-to-cell volume ratio using Ampure XP beads (Beckman Coulter), and eluted in puri-
fied H2O at half the QuickExtract volume (minimum of 12 μL). sjTREC qPCR followed pub-
lished methods [80]. Technical triplicates were assayed by qPCR in fast mode on a
StepOnePlus (Applied Biosystems) using published human-specific sjTREC plasmids in Taq-
Man Fast Advanced Master Mix (Life Technologies) and quantified by comparison to sjTREC
standard plasmid (kindly gifted by Drs. Gregory Sempowski and Daniel Douek) [81]. sjTREC
levels were standardized to cell counts using TaqMan Copy Number Human TERT Reference
Assay (ThermoFisher), according to manufacturer’s instructions. All values with undetectable
wells along with distant CTs were excluded from the analysis.
Quantification of HIV RNA transcripts
Total DNA and RNA were extracted using TRI Reagent. HIV DNA levels (R-U5-tRNA bind-
ing region) were quantified in duplicate using droplet digital PCR and normalized to copies/
million cells using DNA mass (by NanoDrop). Read-through, total initiated (TAR), 5’ elon-
gated (R-U5-trRNA binding region, “Long”), polyadenylated (U3-polyA; "PolyA"), and multi-
ply-spliced (Tat-Rev) HIV transcripts were measured in duplicate by RT-ddPCR as previously
described [82], normalized to copies/μg RNA (approximately one million cells; alternative nor-
malizations were performed using the cell counts from the sorts and DNA recovery), and
divided by the HIV DNA to obtain the average level of HIV RNA/provirus.
Statistical analysis
A two-tailed Wilcoxon matched-pairs signed rank test was used to compare cell subpopula-
tions, and a non-parametric Mann-Whitney U-test to compare between groups. All values
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quoted in the text are medians and interquartile ranges. To assess associations between contin-
uous measurements, we used non-parametric Spearman correlations as well as linear mixed
models for adjusted analyses, transforming variables as appropriate to satisfy model assump-
tions (typically with a log10 transformation). Linear (or logistic) mixed models were also
employed to assess differences between groups when the assumption of similar differences
between groups across each subpopulation appeared valid. Analyses were performed on
GraphPad Prism 7.0 (La Jolla, CA) and Stata 15.0 (College Station, TX). Hierarchical clustering
was performed using the Seaborn package in Python.
Supporting information
S1 Fig. Cell sorting strategy. PBMC were sorted by flow cytometry. From singlets, lympho-
cytes, to live CD3+CD4+ cells, we sorted either the activated (HLA-DR+) fraction or the fol-
lowing subpopulations within the resting (HLA-DR-) fraction according to their expression of
phenotypic markers: naïve (TN, CD45RA+CCR7+CD27+CD57-CD95-), stem-cell memory
(TSCM, CD45RA+CCR7+CD27+CD57-CD95+), central memory (TCM, CD45RA−CCR7
+CD27+), transitional memory (TTM, CD45RA−CCR7−CD27+), effector memory cells
(TEM, CD45RA−CCR7−CD27−) and terminally-differentiated (TTD, CD45RA+CCR7-).
(TIF)
S2 Fig. Characteristics of the deuterium labeling period. CD4 T cell counts, HLA-DR+ and
HLA-DR- CD4 T cell subpopulations label incorporation rates were measured during the
45-day deuterium labeling study and studied at four time points: day 0 (D0), day 15 (D15), day
30 (D30) and day 45 (D45). Some data points are largely overlapping on the graphs for these
participant samples. A. CD4 T cell counts were monitored over time and are shown as cell
number per mm3 of peripheral blood. Longitudinal measurements from the same participants
are shown with a line across the different time points, and uninfected participants are depicted
in black symbols. B. Relative enrichment of deuterium in total HLA-DR+ CD4 T cells in six
HIV-uninfected individuals over the labeling period. C. Fractional synthesis is expressed
based on deuterium enrichment in genomic DNA and expressed at percent increase from D0
at D15, D30 and D45. It is shown for the 24 HIV-infected ART-suppressed participants in rest-
ing naïve (TN), stem-cell memory (TSCM), central memory (TCM), transitional memory
(TTM) and effector memory (TEM) CD4 T cells.
(TIF)
S3 Fig. Treated HIV infection does not change peripheral resting CD4 T cell proportions,
recent thymic emigrants nor IL-15 levels. Peripheral frequencies and thymic output were
assessed in various resting CD4 T cell populations and compared between 24 HIV-infected
(HIV+) and six uninfected (HIV-) participants. We examined the homeostatic properties of
the following resting CD4 T cell subpopulations: naïve (TN), stem-cell memory (TSCM), cen-
tral memory (TCM), transitional memory (TTM), effector memory (TEM) and terminally-dif-
ferentiated (TTD) cells. Medians and interquartile ranges [25–75%] are represented. A. The
peripheral cell frequencies are measured and presented as percentages. Each symbol represents
a participant’s sample. B. Central thymic output is evaluated by measuring cell-associated T
cell Receptor Excision Circles (sjTRECs) in PBMC and in resting CD4 T cell subpopulations.
Results are presented as copy number per million cells for each subtype, and represented on a
log10 y-axis. C. Plasma levels of interleukin-15 (IL-15) (pg/ml) do not statistically differ
between HIV+ and HIV- participants.
(TIF)
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S4 Fig. Resting memory CD4 T cell subpopulations’ contributions to the HIV reservoir in
periphery. HIV DNA and RNA levels were measured in 24 HIV-infected ART-suppressed
participants, and within the following resting CD4 T cell subpopulations: naïve (TN), stem-
cell memory (TSCM), central memory (TCM), transitional memory (TTM) and effector mem-
ory (TEM) cells. A. The contribution of each subpopulation to the total HIV burden in resting
CD4 T cells, whether integrated HIV DNA or cell-associated HIV RNA, were calculated from
the infection levels and relative cell frequencies for each cell type. It reflects the contribution of
each subpopulation to the proviral burden contained in all 5 resting CD4 T cell subpopulations
studied here. Each subpopulation’s contribution is shown as the percentage relative to the
other cell subpopulations. B. The relationship between integrated HIV DNA and cellular half-
life is shown for TSCM cells and represented on a log10 y-axis. Integrated HIV DNA is pre-
sented as copy number per million cells, and cellular half-life is expressed in days. Each symbol
represents a participant sample. Only one cell subpopulation had a significant association
between integrated HIV DNA and cellular half-life, TSCM, which is presented here. C. Distri-
bution and location of shared HIV integration sites among cell subpopulations.
(TIF)
S5 Fig. HIV transcription initiation and elongation levels are higher in resting memory
than naïve CD4 T cell subpopulations. The quantification of various sized HIV transcripts
was performed in eight HIV-infected participants from whom samples were available. The
analysis was carried out on the resting CD4 T cell subpopulations: naïve (TN), central memory
(TCM), transitional memory (TTM) and effector memory (TEM) cells. Total cellular RNA
from each subpopulation was used for a polyadenylation-RT-ddPCR assay for the TAR loop
(the first region transcribed; initiated or total transcripts) and RT-ddPCR assays for HIV
sequence regions suggesting transcriptional interference (“Read-through” transcripts), tran-
scriptional initiation (“TAR”), 5’ transcriptional elongation (“Long”), completion of transcrip-
tion (“PolyA”), and multiple splicing (“Tat-Rev”). Results are presented as the ratio of each
cell-associated HIV RNA to total HIV DNA (both expressed as copies per million cells) to
show the average level of each HIV transcript per provirus. Medians are shown on a log10
scale and only significant p values are indicated.
(TIF)
S6 Fig. ART duration does not impact fractional replacement rate or HIV genomes. The
fractional cellular replacement rate and HIV genome levels are measured in 24 HIV-infected
participants, and within the following resting CD4 T cell subpopulations: naïve (TN), stem-
cell memory (TSCM), central memory (TCM), transitional memory (TTM) and effector mem-
ory (TEM) cells. Antiretroviral therapy (ART) duration is estimated in years, and each symbol
represents a participant’s sample. A. The relationship between the fractional replacement rate
and ART duration was assessed in resting CD4 T cell subpopulations. The fractional replace-
ment rate was estimated as cells produced per day. B. The associations between HIV genomes
and ART duration are shown for all participants in the cells that make up most of the HIV res-
ervoir, i.e. TCM, TTM, and TEM. Integrated HIV DNA and cell-associated HIV RNA are pre-
sented as copy number per million cells of a given subpopulation on a log10 y-axis. Values
below the threshold of detection were calculated for each assay according to the number of
cells analyzed.
(TIF)
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